Archwire Types for Orthodontic Discomfort
(Archwires Trial)
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial aims to determine which of three different orthodontic wires causes the least discomfort for patients. All three wires are commonly used and equally effective, but they might differ in comfort when worn. Participants will receive one of the three wire types, including the 0.016" Ormco 27oC NiTi orthodontic archwire, at the start of their orthodontic treatment. The trial seeks individuals who are healthy, need braces on at least one dental arch, and do not have any nickel allergies. As an unphased trial, this study allows participants to contribute to improving orthodontic comfort for future patients.
Will I have to stop taking my current medications?
If you are currently taking sulfonamides, monoamine oxidase inhibitors, tricyclic antidepressants, phenothiazines, or medical marijuana, you will need to stop before joining the trial.
What prior data suggests that these archwires are safe for orthodontic treatment?
Research has shown that the three types of wires used in braces are generally safe for people. One study found that superelastic nickel-titanium wires might cause more pain in the first 24 hours compared to other wires, but there is no significant difference in long-term discomfort among the different types. This suggests any pain is usually temporary.
For the 0.016" Ormco 27°C and 35°C nickel-titanium wires, studies have shown they effectively straighten teeth without causing major problems. Some research mentions these wires might be more prone to tiny surface pits, but this typically doesn't lead to issues for patients.
Overall, these wires are well-tolerated, and any discomfort usually resolves quickly. The trial aims to determine if one type of wire causes less discomfort than the others, but all three are considered safe based on current research.12345Why are researchers excited about this trial?
Researchers are excited about these orthodontic archwires because they offer a potentially more comfortable experience for patients during initial braces placement, a time typically associated with discomfort. Unlike traditional nickel-titanium (NiTi) archwires that often activate at body temperature, the 0.016" Ormco 27°C and 35°C NiTi archwires are designed to activate at specific, lower temperatures, potentially providing a gentler force on teeth. The 3M Unitek 0.016" Nitinol archwire, also part of the study, is known for its flexibility and consistent force application, potentially reducing pain. These innovative materials and their unique activation properties make them stand out against standard archwires used in orthodontics, sparking interest in their ability to improve patient comfort and treatment outcomes.
What evidence suggests that these archwires could be effective for reducing orthodontic discomfort?
Research has shown that all three types of orthodontic wires in this trial—0.016" Ormco 27°C NiTi, 0.016" Ormco 35°C NiTi, and 3M Unitek 0.016"—are equally effective in straightening teeth. Studies with orthodontic patients have found no significant differences in their effectiveness for improving tooth alignment. For instance, one study found that both NiTi and Cu-NiTi wires improved alignment over six weeks without major differences. Another study supported these findings, showing no significant differences in timing or effectiveness among different flexible nickel-titanium wires. This trial focuses on determining which wire causes the least discomfort for patients, rather than differences in effectiveness.16789
Are You a Good Fit for This Trial?
This trial is for healthy individuals aged 12 or older who need orthodontic treatment with fixed appliances across at least one dental arch. Participants should not have metal allergies, be on certain medications like antidepressants, or use marijuana. Any necessary dental extractions must occur 3 weeks before or after the appliance is fitted.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants receive one of three types of nickel-titanium archwires at the initial bonding appointment
Follow-up
Participants are monitored for changes in pain levels using the Visual Analogue Score (VAS) over the first week after archwire insertion
What Are the Treatments Tested in This Trial?
Interventions
- 0.016" Ormco 27oC NiTi orthodontic archwire
- 0.016" Ormco 35oC NiTi orthodontic archwire
- 3M Unitek 0.016 orthodontic archwire
- Initial Archwire Placement
0.016" Ormco 27oC NiTi orthodontic archwire is already approved in United States, European Union, Canada for the following indications:
- Orthodontic treatment for malocclusion
- Tooth alignment and leveling
- Orthodontic treatment for malocclusion
- Tooth alignment and leveling
- Orthodontic treatment for malocclusion
- Tooth alignment and leveling
Find a Clinic Near You
Who Is Running the Clinical Trial?
University of Colorado, Denver
Lead Sponsor